Company profile: Optivia
1.1 - Company Overview
Company description
- Provider of contract research services for the pharmaceutical industry, advancing the utility of transporter research across pharmacokinetics, toxicology, therapeutic target discovery, and basic biology.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Optivia
TMC Pharma Services
HQ: United Kingdom
Website
- Description: Provider of pharmaceutical and biotech drug development support, offering clinical and nonclinical services, medical support and pharmacovigilance. Capabilities include regulatory strategy and submissions (pre- and post-approval), GxP quality assurance audits and consultancy, medical writing, orphan drug designation applications, paediatric investigation plans, and clinical trial applications with pre-clinical data review/validation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TMC Pharma Services company profile →
Defence Therapeutics
HQ: Canada
Website
- Description: Provider of biopharmaceutical innovations leveraging Accum™ technology, a drug delivery platform that enhances delivery of therapeutic agents to target cells to improve efficacy for cancer and infectious diseases. Offerings include cancer therapeutics, vaccine development for infectious diseases and cancers, antibody-drug conjugates, AccuTOX, and the ARM-002 anti-cancer vaccine shown effective in pre-clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Defence Therapeutics company profile →
Apex Innovative Sciences
HQ: United States
Website
- Description: Provider of independent clinical trial site operations focused on central nervous system indications and other therapeutic areas, including neurology, psychiatry, and addiction, delivering high scientific and clinical quality for client partners and participants.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Apex Innovative Sciences company profile →
Natural Pharmaceuticals
HQ: Poland
Website
- Description: Provider of science- and technology-driven health offerings focused on the Omega-3 segment; a Norwegian market leader dedicated to raising awareness among Central European consumers of the health benefits of diets rich in fish and marine fatty acids.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Natural Pharmaceuticals company profile →
Qointa
HQ: Belgium
Website
- Description: Provider of a compliant, validated eHealth platform for device-agnostic patient monitoring and coaching, enabling direct randomization into adaptive clinical trials. Offers digital transformation and software validation solutions, quality and regulatory support (QMS and risk management), medical device software development, and electronic data integrity services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Qointa company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Optivia
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Optivia
2.2 - Growth funds investing in similar companies to Optivia
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Optivia
4.2 - Public trading comparable groups for Optivia
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →